PC
ZYME icon

Polar Capital’s Zymeworks ZYME Stock Holding History

Polar Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-965,151
Closed -$34.2M – 320
2020
Q1 		$34.2M Buy
965,151
+30,196
+3% +$1.24M 0.37% 80
2019
Q4 		$42.5M Buy
934,955
+884,955
+1,770% +$32.2M 0.37% 89
2019
Q3 		$1.24M Buy
+50,000
New +$1.25M 0.01% 260

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Polar Capital's ZYME Position: Q2 2020 in Review

Polar Capital sold out of Zymeworks (ZYME) in Q2 2020, closing a stake of 965,151 shares — an estimated $34.2M sold.

Polar Capital first reported a position in ZYME in Q3 2019 and held it in 3 quarters. The position peaked at $42.5M in Q4 2019. 133 funds tracked by Wall St. Rank hold ZYME as of Q2 2020.

  • Polar Capital reported no remaining Zymeworks position as of Q2 2020 after selling out during the quarter.
  • Polar Capital sold 965,151 Zymeworks shares in Q2 2020, an estimated $34.2M.
  • Polar Capital first reported a position in Zymeworks in Q3 2019 and held it in 3 quarters.
  • Polar Capital's Zymeworks position peaked at $42.5M in Q4 2019.
  • 133 funds tracked by Wall St. Rank held Zymeworks as of Q2 2020.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.